PILOT Primary Analysis and Meta-Analysis of CAR-T Therapy versus SOC for 2L Treatment of R/R LBCL

Dr Jeremy S. Abramson evaluates data from the primary analysis of the PILOT study and a meta-analysis of CAR-T therapy versus standard-of-care for second-line treatment of refractory or relapsed LBCL.

Related Items

Conference Correspondent Coverage is Brought to You by the Publishers of:
Oncology Practice Management
The Oncology Nurse–APN/PA

Learn more about our family of publications.

View Our Publications